ADA’s Review of the New Orleans Expulsions Is Still Ongoing, Officials Say

It feels like the story that started with a dramatic showdown at the ADA’s June 5 conference in New Orleans is still playing out. On Sept. 1, the association released a brief set of “top‑line findings” from an internal panel that was tasked with dissecting why five outspoken members were suddenly escorted out.

But the paper trail ends there. The full report remains locked behind closed doors, and, as the ADA’s audit and governance committee (AGC) made clear on Sunday, the work is not done.

“The AGC has notified the Board that its initial findings did not take into account the full breadth and depth of the AGC’s investigation and certain interviews that were conducted after the initial findings were prepared,” the committee’s statement read. In plain English, they’re saying they missed a chunk of the puzzle and are now going back to fill the gaps.

That admission comes with a bit of a pause button for anyone waiting for a clean answer. The AGC says additional findings will be presented to the Board, which could “clarify or correct information previously provided” and might even trigger “further actions.” In other words, we could see more expulsions—or perhaps a reversal—depending on what those missing pieces reveal.

The backdrop to all this is a heated debate that has been echoing through the diabetes community for weeks. The five expelled members – all researchers or clinicians with a track record of public commentary on diabetes policy – were removed after a series of heated exchanges that some say crossed a line, while others argue they were simply being silenced for dissenting opinions.

What makes the ADA’s current stance interesting is the balance it tries to strike. On one hand, the association wants to demonstrate that it takes misconduct seriously; on the other, it can’t afford the perception that it’s muzzling scientific debate. The AGC’s note that “additional findings are expected” seems like an attempt to buy time while still signaling that the organization is listening.

For now, the details remain under lock‑step confidentiality. ADA officials have hinted that the final report may be released later in the year, but there’s no firm deadline. In the meantime, the expelled members continue to speak out, leveraging social media, academic blogs, and even a few op‑eds to keep the conversation alive.

It’s a reminder that professional societies walk a tightrope between maintaining decorum and fostering open discourse. The ADA’s next move will likely set a precedent for how other medical organizations handle internal dissent moving forward.

So, while the headline says the review isn’t final, the real takeaway is that the debate is far from over. Keep an eye on the board’s next briefing – it could reshape the way the diabetes community talks about itself, and maybe even how it talks about patients.